Equities

Abingdon Health PLC

ABDX:LSE

Abingdon Health PLC

Health CareMedical Equipment and Services
  • Price (GBX)10.50
  • Today's Change0.245 / 2.39%
  • Shares traded3.38k
  • 1 Year change-12.54%
  • Beta-0.4923
Data delayed at least 20 minutes, as of Jun 28 2024 10:01 BST.
More ▼

Profile data is unavailable for this security.

About the company

Abingdon Health plc provides lateral flow contract development and manufacturing (CDMO services) and related contract services to an international customer base. It offers its services to an international customer base across industry sectors, which include clinical, self-testing, animal health, plant health, and environmental testing. Its segments include Product sales, Contract manufacturing, Contract development, and Regulatory. Its regulatory services include technical file build, regulatory filing support, implementation of quality management systems and quality assurance. The Company’s CDMO division offers product development, regulatory support, technology transfer and manufacturing services for customers looking to develop new assays or transfer existing laboratory-based assays to a lateral flow format. Its Abingdon Simply Test range of self-tests is an e-commerce platform that offers a range of self-tests to enable consumers to manage their own health and wellbeing.

  • Revenue in GBP (TTM)5.34m
  • Net income in GBP-2.24m
  • Incorporated2008
  • Employees82.00
  • Location
    Abingdon Health PLCYork Biotech Campus, Sand HuttonYORK YO41 1LZUnited KingdomGBR
  • Phone+44 19 0440 6050Fax+44 19 0446 2122
  • Websitehttps://www.abingdonhealth.com/
More ▼

Peer analysis

CompanyRevenue (TTM)Net income (TTM)Market capEmployeesMarket Cap /
Employees
Cambridge Nutritional Sciences PLC9.05m-3.21m8.69m91.008.69m91.00
ImmuPharma PLC0.00-2.92m8.93m5.008.93m5.00
Genflow Biosciences PLC0.00-1.63m9.09m5.009.09m5.00
Kanabo Group PLC895.00k-7.99m9.17m20.009.17m20.00
Destiny Pharma PLC0.00-5.66m9.38m19.009.38m19.00
Bivictrix Therapeutics PLC0.00-2.55m10.32m10.0010.32m10.00
Chill Brands Group PLC146.62k-3.64m10.89m2.0010.89m2.00
Synairgen plc0.00-9.99m11.23m30.0011.23m30.00
Genincode PLC2.16m-7.02m11.95m36.0011.95m36.00
Proteome Sciences plc5.03m-2.44m12.25m35.0012.25m35.00
Abingdon Health PLC5.34m-2.24m12.99m82.0012.99m82.00
Provexis plc598.08k-496.59k13.58m2.0013.58m2.00
LungLife AI Inc36.40k-4.28m14.15m15.0014.15m15.00
Shield Therapeutics PLC13.09m-33.29m14.47m73.0014.47m73.00
OptiBiotix Health PLC689.10k-13.17m15.67m3.0015.67m3.00
Verici DX PLC801.55k-6.91m15.82m14.0015.82m14.00
Data as of Jun 28 2024. Currency figures normalised to Abingdon Health PLC's reporting currency: UK Pound GBX

Institutional shareholders

9.75%Per cent of shares held by top holders
HolderShares% Held
Hargreaves Lansdown Asset Management Ltd.as of 08 Sep 202310.43m8.23%
Unicorn Asset Management Ltd.as of 31 May 20241.93m1.52%
Data from 31 May 2024 - 03 Jun 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.